N-Isobutylbenzo[d]thiazol-2-amine

Catalog No.: 
ACOBOJ760
CAS No.: 
24622-32-0
Molecular Formula: 
C11H14N2S
Molecular Weight: 
206.31
N-Isobutylbenzo[d]thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00InquiryInquiry
100mg95%$100.00InquiryInquiry
250mg95%$131.00InquiryInquiry
1g95%$336.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Isobutylbenzo[d]thiazol-2-amine
IUPAC NameN-isobutylbenzo[d]thiazol-2-amine
MDL No.MFCD03152764
Molecular FormulaC11H14N2S
Molecular Weight206.31
SMILESCC(C)CNC1=NC2=CC=CC=C2S1
InChI KeySMGKWHWIOTWYOI-UHFFFAOYSA-N
Synonym2-Benzothiazolamine,N-(2-methylpropyl)-(9CI);N-(2-Methylpropyl)-2-benzothiazolamine;N-(2-methylpropyl)-1,3-benzothiazol-2-amine;N-isobutylbenzo[d]thiazol-2-amine;2-Benzothiazolamine, N-(2-methylpropyl)-
CAS No.24622-32-0

Synthetic Route by SureRoute

1. ACOBOJ760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLSKC139 route compound structure diagram
    ACLSKC13974098-36-5In Stock
  2. Plus
  3. ACQZGK630 route compound structure diagram
    ACQZGK630615-20-3In Stock
  4. Then
  5. ACOBOJ760 route product structure diagram
    ACOBOJ76024622-32-0
Inquiry

2. ACOBOJ760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRDHS291 route compound structure diagram
    ACRDHS2912516-40-7In Stock
  2. Plus
  3. ACLSKC139 route compound structure diagram
    ACLSKC13974098-36-5In Stock
  4. Then
  5. ACOBOJ760 route product structure diagram
    ACOBOJ76024622-32-0
Inquiry

3. ACOBOJ760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLZNR081 route compound structure diagram
    ACLZNR08194787-08-3In Stock
  4. Then
  5. ACOBOJ760 route product structure diagram
    ACOBOJ76024622-32-0
Inquiry

Comments (0)